January 23
2022
download app
download appDOWNLOAD OUR APP
download google-play
download app-store
Emilija Berzanskaite
share
3rd January 2022
Consumer, Health & Environment Covid-19

Multiple applicants challenge Commission’s failure to include certain testing in preclinical phase for COVID-19 vaccines

Official publication has been made of an action (T-695/21) brought by 775 applicants against the European Commission for its failure to include carcinogenicity and genotoxicity testing in the preclinical phase for the mRNA-technology vaccines, such as to fight Covid-19.  

In addition to declaring that the Commission acted unlawfully, the applicants request the General Court to order the Commission to include carcinogenicity and genotoxicity testing in the preclinical phase for the mentioned vaccines and to disclose the clear legislative basis as to why the testing at issue was not included and the regulation setting out the mandatory checks required for the authorisation of mRNA-technology vaccines. 

In support of the actio

×

Your privacy is important for us

We use cookies to improve the user experience. Please review privacy preferences.

Accept all Settings

Check our privacy policy and cookies policy.

Cookies